Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04778410
Title Study of Magrolimab Combinations in Participants With Myeloid Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences

acute myeloid leukemia


Azacitidine + Hu5F9-G4 + Venetoclax

Cytarabine + Etoposide + Hu5F9-G4 + Mitoxantrone

Azacitidine + Hu5F9-G4

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.